Seeing Is Believing
Currently out of the existing stock ratings of Michael Morabito, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Michael Morabito, currently employed carries an average stock price target met ratio of 40.28% that have a potential upside of 39.64% achieved within 215 days.
Michael Morabito’s has documented 36 price targets and ratings displayed on 8 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on AXLA, Axcella Health at 02-Nov-2022.
Analyst best performing recommendations are on MRTX (MIRATI THER).
The best stock recommendation documented was for MRTX (MIRATI THER) at 8/7/2020. The price target of $140 was fulfilled within 10 days with a profit of $11.12 (8.63%) receiving and performance score of 8.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$3.99 (395.05%)
$6
8 months 5 days ago
(01-Apr-2024)
1/5 (20%)
$3.89 (350.45%)
34
Buy
1 years 3 months 26 days ago
(10-Aug-2023)
0/2 (0%)
$27.7 (101.47%)
Buy
1 years 3 months 26 days ago
(10-Aug-2023)
0/1 (0%)
$42.3 (238.98%)
Buy
$27
$24.51 (984.34%)
$32
1 years 3 months 26 days ago
(10-Aug-2023)
0/2 (0%)
$25.57 (661.71%)
Buy
$80
$78.99 (7820.79%)
3 years 7 months 1 days ago
(05-May-2021)
1/4 (25%)
$62.3 (351.98%)
343
What Year was the first public recommendation made by Michael Morabito?